{"id":"W2591871775","doi":"10.1182/blood.v128.22.3110.3110","title":"A Pooled Overall Survival (OS) Analysis of 5-Year Data from the COMFORT-I and COMFORT-II Trials of Ruxolitinib for the Treatment of Myelofibrosis (MF)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; International Prognostic Scoring System; Internal medicine; Clinical endpoint; Clinical trial; Hazard ratio; Placebo; Surrogate endpoint; Crossover study; Surgery; Confidence interval; Myelodysplastic syndromes; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02695596,0.002143515,0.005846575,0.002950807,0.0003375296,0.001716206,0.0009682176,0.001270352,0.002642329],"category_scores_gemma":[0.01659537,0.0006024557,0.01879397,0.001831063,0.0005359729,0.001370962,0.001382156,0.001262453,0.0002873648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008068226,"about_ca_system_score_gemma":0.0005869751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006334872,"about_ca_topic_score_gemma":0.001132724,"domain_scores_codex":[0.982863,0.01197011,0.001818136,0.001817521,0.001122873,0.0004082799],"domain_scores_gemma":[0.9834386,0.008539573,0.004857245,0.001594952,0.001088482,0.0004811409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.3897394,0.000407244,0.06546082,0.0100575,0.5012832,0.0002290978,0.000145761,0.004368012,0.003390887,0.0002229921,0.002052341,0.02264282],"study_design_scores_gemma":[0.05608427,0.04701307,0.241788,0.001086625,0.6373358,0.0005934775,0.0003212024,0.006559823,0.002213063,0.0009314243,0.005854102,0.0002190903],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8540143,0.1240786,0.004848241,0.0003870943,0.0004281635,0.0009771866,0.01281617,0.0001842907,0.002265756],"genre_scores_gemma":[0.9855905,0.003747113,0.001365524,0.0002734935,0.0002265547,0.0006563938,0.007670651,0.00003548947,0.0004343106],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02695596,"threshold_uncertainty_score":0.1425585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1217421372189161,"score_gpt":0.3517957853429673,"score_spread":0.2300536481240513,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}